durvalumab - Robuta Search

https://adisinsight.springer.com/trials/700384801?error=cookies_not_supported&code=7d46de5a-e19a-4405-b61f-4fa7091ad63a Phase I Trial of Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab... Based on preclinical data from the Lim lab (WUSM), the investigators hypothesize that IRAK4 inhibition cripples tumor-intrinsic survival signaling and https://www.goodrx.com/imfinzi/what-is Imfinzi (durvalumab)i: Dosage, Side Effects, Alternatives & More - GoodRx Learn about Imfinzi (durvalumab) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives. side effects durvalumab dosage alternatives goodrx https://adisinsight.springer.com/drugsafety/803924249?error=cookies_not_supported&code=19b498bc-2539-42cd-be9d-b9627785893a Durvalumab/Tremelimumab - AdisInsight A patient with hepatitis C virus (HCV)-related hepatocellular carcinoma developed hepatitis following treatment with durvalumab and tremelimumab. durvalumab adisinsight https://pure.skku.edu/en/publications/durvalumab-as-third-line-or-later-treatment-for-advanced-non-smal/ Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an... https://ecancer.org/en/video/12451-durvalumab-and-tremelimumab-show-manageable-safety-in-poor-prognosis-hcc Durvalumab and tremelimumab show manageable safety in poor-prognosis HCC - ecancer Prof Stephen Chan speaks to ecancer about the safety results from the phase 3b SIERRA study of durvalumab and tremelimumab as first-line treatment for hepatocel durvalumab show manageable https://www.cancernetwork.com/view/durvalumab-combo-yields-survival-benefit-in-advanced-endometrial-cancer Durvalumab Combo Yields Survival Benefit in Advanced Endometrial Cancer | CancerNetwork May 15, 2026 - Data from the phase 3 DUO-E trial indicate that the safety of durvalumab/chemotherapy with or without olaparib/durvalumab or durvalumab monotherapy maintenance... endometrial cancer durvalumab combo yields survival https://kolpulse.com/kol-pulse-trial-profile-adriatic KOL Pulse Trial Profile - ADRIATIC | Imfinzi (durvalumab) in Limited-stage SCLC AI-generated KOL intelligence for ADRIATIC. Imfinzi (durvalumab) in Limited-stage SCLC. kol pulse trial profile adriatic https://www.georgiacancerinfo.org/clinical-trials/detail/5875 A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract... https://adisinsight.springer.com/drugsafety/803925804?error=cookies_not_supported&code=ed46ec81-b1fa-4437-a023-db42d221b9a1 Durvalumab - AdisInsight Six patients with stage III non-small cell lung cancer developed grade 3 or higher pneumonitis following treatment with radiochemotherapy and subsequent durvalumab adisinsight https://ecancer.org/en/video/9652-mermaid-2-phase-3-study-of-durvalumab-in-patients-with-resected-stage-mrd-ii-iii-nsclc MERMAID-2: Phase 3 study of durvalumab in patients with resected stage MRD II-III NSCLC - ecancer Dr David Spigel speaks to ecancer about the on-going MERMAID-2 phase 3 study of durvalumab in patients with resected, stage II-III NSCLC who become MRD posit https://dzl.de/publication/10-1038-s41591-024-02808-y/ Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase... For patients with non-small-cell lung cancer (NSCLC) tumors without currently targetable molecular alterations, standard-of-care treatment is immunotherapy... https://www.myhealthtoolkit.com/web/public/brands/medicalpolicy/external-policies/imfinzi-durvalumab/ Imfinzi (durvalumab) durvalumab https://digitalcommons.library.tmc.edu/uthgsbs_docs/2330/ "Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalu" by Shannon N Westin,... PURPOSE: Immunotherapy and chemotherapy combinations have shown activity in endometrial cancer, with greater benefit in mismatch repair (MMR)-deficient (dMMR)... durvalumab plus carboplatin paclitaxel followed https://www.oncologiatoracica.it/dettnews-uso_compassionavole_di_durvalumab/1014_38/ita/ Bacheca - USO COMPASSIONAVOLE DI DURVALUMAB - Aiot - Associazione Italiana Oncologia Toracica Aiot - Associazione Italiana Oncologia Toracica bacheca uso di durvalumab aiot https://adisinsight.springer.com/drugsafety/803929009?error=cookies_not_supported&code=1f06c830-f1a7-4279-88c0-fb7d65ab7912 Durvalumab - AdisInsight A 69-year-old woman with lung carcinoma receiving durvalumab [dose, route and duration not stated] experienced kidney injury and pauci-immune durvalumab adisinsight https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-durvalumab-and-domvanalimab-for-non-small-cell-lung-cancer-pacific-8 Cancer Research UK | A trial of durvalumab and domvanalimab for non small cell lung cancer... This trial is looking at durvalumab and domvanalimab for non small cell lung cancer that has grown into surrounding tissues. cancer research uk https://www.leberkrebshilfe.info/lexikon/durvalumab.html Durvalumab - LeberKrebsHilfe.info Mediakament, das bei der systemischen Therapie zum Einsatz kommen kann. durvalumab info https://scottishmedicines.org.uk/medicines-advice/durvalumab-imfinzi-full-smc2818/ durvalumab (Imfinzi) durvalumab https://cholangiocarcinomanewzealand.org/durvalumab-plus-gemcitabine-and-cisplatin-in-advanced-biliary-tract-cancer/ Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer - Cholangiocarcinoma New... Dec 2, 2022 - The TOPAZ-1 trial evaluated durvalumab plus chemotherapy for patients with advanced biliary tract cancer https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00772 Durvalumab and Tremelimumab, Oleclumab, or Monalizumab in Treating Patients with Colorectal Cancer... Durvalumab and Tremelimumab, Oleclumab, or Monalizumab in Treating Patients with Colorectal Cancer with Lung or Liver Metastases That Can Be Removed by Surgery